Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
2162 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
HK$60
Buy
33.33%
Upside
Reiterated
12/30/24
Citi Reiterates Buy Rating on Keymed Biosciences Inc (2162:HK)Citi analyst Wangbin Zhou reiterated a Buy rating and HK$60.00 price target on Keymed Biosciences Inc (2162:HK).
Huatai Securities
HK$60.93
Buy
35.40%
Upside
Reiterated
12/24/24
Huatai Financial Reiterates Buy (1) Rating on Keymed Biosciences Inc (2162:HK)Huatai Financial analyst Dai Wen reiterated a Buy (1) rating and HK$60.93 price target on Keymed Biosciences Inc (2162:HK).
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
HK$60
Buy
33.33%
Upside
Reiterated
12/30/24
Citi Reiterates Buy Rating on Keymed Biosciences Inc (2162:HK)Citi analyst Wangbin Zhou reiterated a Buy rating and HK$60.00 price target on Keymed Biosciences Inc (2162:HK).
Huatai Securities
HK$60.93
Buy
35.40%
Upside
Reiterated
12/24/24
Huatai Financial Reiterates Buy (1) Rating on Keymed Biosciences Inc (2162:HK)Huatai Financial analyst Dai Wen reiterated a Buy (1) rating and HK$60.93 price target on Keymed Biosciences Inc (2162:HK).
Best Analysts Covering Keymed Biosciences, Inc.
Which Analyst Should I Follow If I Want to Buy HK:2162 and Sell After:
1 Month
xxx
Success Rate
0/1 ratings generated profit
Average Return
-1.80%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -1.80% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+49.70%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +49.70% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+41.90%
reiterated a buy rating 4 months ago
Copying Wangbin Zhou's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +41.90% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+41.90%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2162 Analyst Recommendation Trends
Rating
Aug 23
Dec 24
Strong Buy
0
2
Buy
2
2
Hold
0
0
Sell
0
0
Strong Sell
0
0
total
2
4
Each month's total comprises the sum of three months' worth of ratings.
2162 Stock Forecast FAQ
What is HK:2162’s average 12-month price target, according to analysts?
Based on analyst ratings, Keymed Biosciences, Inc.’s 12-month average price target is 60.00.
What is HK:2162’s upside potential, based on the analysts’ average price target?
Keymed Biosciences, Inc. has 33.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Keymed Biosciences, Inc. a Buy, Sell or Hold?
Keymed Biosciences, Inc. has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Keymed Biosciences, Inc.’s share price target?
The average share price target for Keymed Biosciences, Inc. is 60.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$60.00 ,and the lowest forecast is HK$60.00. The average share price target represents 33.33% Increase from the current price of HK$45.
The highest analyst share price target is HK$60.00 ,and the lowest forecast is HK$60.00. The average share price target represents 33.33% Increase from the current price of HK$45.
What do analysts say about Keymed Biosciences, Inc.?
Keymed Biosciences, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Keymed Biosciences, Inc.?
To buy shares of HK:2162, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.